8-K: Enphys Acquisition Corp. to Delist from NYSE, Continues Trading on OTC Pink

Enphys Acquisition Corp. will be delisted from the NYSE after withdrawing its appeal, and will continue trading on the OTC Pink Marketplace.

Summary

• Enphys Acquisition Corp. was notified by the NYSE on July 24, 2024, that it no longer met the minimum listing requirements due to its market capitalization falling below $40 million.
• Trading of the company's Class A ordinary shares, units, and warrants on the NYSE was suspended after the market closed on July 24, 2024.
• The company's securities began trading on the OTC Pink Marketplace on July 25, 2024, under the ticker symbols NFSCF, NFSUF, and NFSWF, respectively.
• Enphys initially requested a review of the delisting decision by a NYSE committee, but withdrew this request on October 10, 2024.
• The NYSE filed a Form 25 with the SEC on October 10, 2024, to officially delist the company's securities, which will be effective 10 days after the filing date.
• The company's securities will continue to trade on the OTC Pink Marketplace after the delisting from the NYSE.

Sentiment

Score: 3

Explanation: The document indicates a negative event (delisting from NYSE) due to failure to meet listing requirements, which is generally viewed unfavorably by investors.

Positives

• The company's securities will continue to trade on the OTC Pink Marketplace, ensuring continued liquidity for investors.

Negatives

• The company failed to maintain the NYSE's minimum market capitalization requirement of $40 million.
• The company's securities were suspended from trading on the NYSE.
• The company withdrew its appeal against the delisting.

Risks

• Delisting from the NYSE may negatively impact investor confidence and the company's ability to raise capital in the future.
• Trading on the OTC Pink Marketplace may result in lower trading volumes and potentially higher volatility compared to the NYSE.

Future Outlook

The company's securities will continue to trade on the OTC Pink Marketplace following the delisting from the NYSE.

Management Comments

• The report was signed by Jorge de Pablo, Chief Executive Officer of Enphys Acquisition Corp.

Industry Context

Delistings from major exchanges can occur when companies fail to meet listing requirements, which can be a sign of financial distress or poor performance. This is not uncommon for smaller or less established companies.

Comparison to Industry Standards

• Companies listed on major exchanges like the NYSE are expected to maintain certain financial and operational standards, including a minimum market capitalization. Enphys's failure to meet this standard is a negative signal compared to other listed companies.
• The move to the OTC Pink Marketplace is common for companies that have been delisted from major exchanges, but it typically results in lower trading volumes and less visibility compared to companies listed on the NYSE. Companies like Enphys that have been delisted from the NYSE are often compared to other companies on the OTC market.

Stakeholder Impact

• Shareholders may experience a decrease in the value of their investment due to the delisting.
• The company may face challenges in raising capital in the future due to the delisting.
• Employees may experience uncertainty about the company's future.

Next Steps

• The company's securities will continue to trade on the OTC Pink Marketplace.
• The delisting from the NYSE will be effective 10 days after the Form 25 filing on October 10, 2024.

Key Dates

Keywords

delisting, NYSE, OTC Pink, market capitalization, trading suspension, Form 25, NFSCF, NFSUF, NFSWF